Impilo Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Impilo has acquired 3 companies.

Impilo’s most common sectors for investment arelife science (30%) and healthcare services (20%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (80%) and secondary buyout (20%). In total, Impilo has invested in 4 different countries.

In the last 3 years, Impilo has exited 1 company. The Firm’s most common exit type is trade sale (100%).

Join Mergr to view Impilo’s full profile and discover more middle-market private equity firm investors just like it.

M&A Summary

  • M&A Total Activity11
    • M&A Buy Activity10
    • M&A Sell Activity1
  • Total Sectors Invested 6
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 2

Impilo

Impilo AB

Regeringsgatan 48,
Stockholm, SE-111 56
Sweden
+46 8 401 00 60
www.impilo.se
info@impilo.se

Impilo is a private investment firm focused exclusively on on investments in Nordic companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Impilo prefers majority investments, but will consider select minority situations. Target companies are generally valued between SEK 200 million and SEK 1.5 billion. Impilo has offices in Stockholm and Copenhagen.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout, Venture

Geographic Preferences: Nordic

Transaction Criteria Min Max
Target Revenue 200 1,500
Target EBITDA - -
Investment Size 100 1,000
Enterprise Value - -
values in millions of SEK

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.8/yr) # 6 1 1 2 - - 10
Sell (0.2/yr) # - - 1 - - - 1
  11

Most Recent M&A

Company Date Value Type
Lowenco A/S 2022-02-03 - Buyout (LBO, MBO, MBI)
Vamdrup, Denmark · www.lowenco.com
tandlægen.dk 2022-01-03 - Buyout (LBO, MBO, MBI)
Lyngby, Denmark · www.tandlaegen.dk
NutraQ AS 2021-06-15 - Trade Sale
Oslo, Norway · www.nutraq.com
Scantox A/S 2021-01-20 - Buyout (LBO, MBO, MBI)
Lille Skensved, Denmark · www.scantox.com
Mallax Pharmaceuticals 2020-12-15 - Buyout (LBO, MBO, MBI)
Stockholm, Sweden · www.mallaxpharma.com
Euro Accident Livförsäkring AB 2019-09-03 - Buyout (LBO, MBO, MBI)
Danderyd, Sweden · www.euroaccident.se
TFP Ltd. 2019-03-28 - Secondary Buyout
Oxford, United Kingdom · www.thefertilitypartnership.com
Humana AB 2019-01-14 - Secondary Buyout
Stockholm, Sweden · www.humana.se
Immedica Pharma AB 2018-07-30 - Buyout (LBO, MBO, MBI)
Stockholm, Sweden · www.immedica.com
NutraQ AS 2017-12-01 - Buyout (LBO, MBO, MBI)
Oslo, Norway · www.nutraq.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Scantox A/S 2021-01-20 QPS Neuro 2023-11-30 1
Lille Skensved, Denmark · www.scantox.com Grambach, Austria · www.qpsneuro.com
TFP Ltd. 2019-03-28 VivaNeo Deutschland GmbH 2019-07-11 1
Oxford, United Kingdom · www.thefertilitypartnership.com Frankfurt, Germany · www.vivaneo-ivf.com

M&A by Sector

Sector Current # Value All-time # Value
Life Science 3 (38%) - 3 (30%) -
Healthcare Services 2 (25%) - 2 (20%) -
Medical Products - - 2 (20%) -
Business Services 1 (13%) - 1 (10%) -
Insurance 1 (13%) - 1 (10%) -
Manufacturing 1 (13%) - 1 (10%) -
Total 8 - 10 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
Sweden 4 (50%) - 4 (40%) -
Denmark 3 (38%) - 4 (40%) -
United Kingdom 1 (13%) - 1 (10%) -
Norway - - 1 (10%) -
Total 8 - 10 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 6 (75%) - 8 (80%) -
Secondary Buyout 2 (25%) - 2 (20%) -
Total 8 - 10 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 1 (100%) -
Total 1 -

M&A Connections

Deals
Acquired from
Investor(s)
20%
2 (20%)
Exited to
Strategic(s)
100%
1 (100%)

FAQ

What type of investor is Impilo?

Impilo is a private equity firm.

Where is Impilo headquartered?

Impilo is headquartered in Stockholm, Sweden.

 Subscribe to unlock this and 199,698
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 191K M&A Transactions
  • 195K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.